Basic Information
| RNALocate ID: | RLID-D:11001520 |
| RNA Symbol: | hsa-miR-200c-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-200c-5p |
| RNA ID: | miRBase:MIMAT0004657 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11003842 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11004086 | Microvesicle | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-200c-5p | Large cell neuroendocrine cancer | MNDR-E-MI-26445 |
| MNDR | hsa-miR-200c-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-26446 |
| MNDR | hsa-miR-200c-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-26447 |
| MNDR | hsa-miR-200c-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-26448 |
| MNDR | hsa-miR-200c-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-26449 |
| MNDR | hsa-miR-200c-5p | Prostate cancer | MNDR-E-MI-26450 |
| MNDR | hsa-miR-200c-5p | Gastric cancer | MNDR-E-MI-26451 |
| MNDR | hsa-miR-200c-5p | Parkinson disease | MNDR-E-MI-26452 |
| MNDR | hsa-miR-200c-5p | Breast cancer | MNDR-E-MI-26453 |
| MNDR | hsa-miR-200c-5p | Pituitary neoplasms | MNDR-E-MI-26454 |
| MNDR | hsa-miR-200c-5p | Pancreatic cancer | MNDR-E-MI-26455 |
| MNDR | hsa-miR-200c-5p | Rectum adenocarcinoma | MNDR-E-MI-26456 |
| MNDR | hsa-miR-200c-5p | Colon cancer | MNDR-E-MI-26457 |
| MNDR | hsa-miR-200c-5p | Colon adenocarcinoma | MNDR-E-MI-26458 |
| MNDR | hsa-miR-200c-5p | Prostate adenocarcinoma | MNDR-E-MI-26459 |
| MNDR | hsa-miR-200c-5p | Carcinoma ductal breast | MNDR-E-MI-26460 |
| MNDR | hsa-miR-200c-5p | Glioblastoma | MNDR-E-MI-26461 |
| MNDR | hsa-miR-200c-5p | Breast carcinoma | MNDR-E-MI-26462 |
| MNDR | hsa-miR-200c-5p | Gastric adenocarcinoma | MNDR-E-MI-26463 |
| MNDR | hsa-miR-200c-5p | Cervical squamous cell carcinoma | MNDR-E-MI-26464 |
| MNDR | hsa-miR-200c-5p | Pituitary adenoma | MNDR-E-MI-26465 |
| MNDR | hsa-miR-200c-5p | Lung squamous cell carcinoma | MNDR-E-MI-26466 |
| MNDR | hsa-miR-200c-5p | Lung adenocarcinoma | MNDR-E-MI-26467 |
| MNDR | hsa-miR-200c-5p | Thyroid carcinoma | MNDR-E-MI-26468 |
| MNDR | hsa-miR-200c-5p | Ovarian carcinoma | MNDR-E-MI-26469 |
| MNDR | hsa-miR-200c-5p | Bladder urothelial carcinoma | MNDR-E-MI-26470 |
| MNDR | hsa-miR-200c-5p | Carcinoma renal cell | MNDR-E-MI-26471 |
| MNDR | hsa-miR-200c-5p | Cholangiocarcinoma | MNDR-E-MI-26472 |
| MNDR | hsa-miR-200c-5p | Esophageal cancer | MNDR-E-MI-26473 |
| MNDR | hsa-miR-200c-5p | Lung small cell carcinoma | MNDR-E-MI-26474 |
| MNDR | hsa-miR-200c-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-26475 |
| MNDR | hsa-miR-200c-5p | Breast invasive carcinoma | MNDR-E-MI-26476 |
| MNDR | hsa-miR-200c-5p | Burkitt lymphoma | MNDR-E-MI-26477 |
| MNDR | hsa-miR-200c-5p | Colorectal cancer | MNDR-E-MI-26478 |
| MNDR | hsa-miR-200c-5p | Breast cancer her3+ negative | MNDR-E-MI-26479 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | BMI1 | Homo sapiens | RR00226523 |
TOP